Abstract:Aim: Leflunomide is an immunosuppressive agent marketed as a disease-modifying antirheumatic drug. But it causes severe side effects, including fatal hepatitis and liver failure. In this study we investigated the contributions of hepatic metabolism and transport of leflunomide and its major metabolite teriflunomide to leflunomide induced hepatotoxicity in vitro and in vivo . Methods: The metabolism and toxicity of leflunomide and teriflunomide were evaluated in primary rat hepatocytes in vitro . Hepatic cytochrome P450 reductase null ( HRN ) mice were used to examine the PK profiling and hepatotoxicity of leflunomide in vivo . The expression and function of sodium/bile acid cotransporter (NTCP) were assessed in rat and human hepatocytes and NTCP-transfected HEK293 cells. After Male Sprague-Dawley (SD) rats were administered teriflunomide (1,6, 12 mg·kg −1 ·d −1 , ig) for 4 weeks, their blood samples were analyzed. Results: A nonspecific CYPs inhibitor aminobenzotriazole (ABT, 1 mmol/L) decreased the IC 50 value of leflunomide in rat hepatocytes from 409 to 216 μmol/L, whereas another nonspecific CYPs inhibitor proadifen (SKF, 30 μmol/L) increased the cellular accumulation of leflunomide to 3.68-fold at 4 h. After oral dosing (15 mg/kg), the plasma exposure (AUC 0-t ) of leflunomide increased to 3-fold in HRN mice compared with wild type mice. Administration of leflunomide (25 mg·kg −1 ·d −1 ) for 7 d significantly increased serum ALT and AST levels in HRN mice; when the dose was increased to 50 mg·kg −1 ·d −1 , all HRN mice died on d 6. Teriflunomide significantly decreased the expression of NTCP in human hepatocytes, as well as the function of NTCP in rat hepatocytes and NTCP-transfected HEK293 cells. Four-week administration of teriflunomide significantly increased serum total bilirubin and direct bilirubin levels in female rats, but not in male rats. Conclusion: Hepatic CYPs play a critical role in detoxification process of leflunomide, whereas the major metabolite teriflunomide suppresses the expression and function of NTCP, leading to potential cholestasis.

A 771726, the Active Metabolite of Leflunomide, Inhibits TNF-α and IL-1 from Kupffer Cells

Leflunomide attenuates hepatocyte injury by inhibiting Kupffer cells.

[Effects of Leflunomide and Its Active Metabolite on the Production and Mrna Expression of TNF-alpha in Peritoneal Macrophages and Synovial Cells with Adjuvant Arthritis in Rats].

[The active metabolite of leflunomide A771726 inhibits proliferation and collagen synthesis of hepatic stellate cell].

SINGLE NUCLEOTIDE POLYMORPHISM IN IFN WAS ASSOCIATED WITH ACUTE REJECTION AFTER LIVER TRANSPLANTATION

Inhibition of Hepatic Cytochrome P450 Enzymes and Sodium/bile Acid Cotransporter Exacerbates Leflunomide-Induced Hepatotoxicity.

Effect of Leflunomide on Immunological Liver Injury in Mice

Mitochondrial Dysfunction Induced by Leflunomide and Its Active Metabolite.

Inhibition of canonical WNT/β-catenin signaling is involved in leflunomide (LEF)-mediated cytotoxic effects on renal carcinoma cells.

Inhibitory Effect Of Leflunomide On Hepatic Fibrosis Induced By Ccl4 In Rats

Osteoclast Differentiation Inhibited by Active Metabolite of Leflunomide through Regulating NFATc1 Expression

Honokiol: an effective inhibitor of tumor necrosis factor-α-induced up-regulation of inflammatory cytokine and chemokine production in human synovial fibroblasts

Leflunomide Induces Immunosuppression in Collagen-Induced Arthritis Rats by Upregulating CD4+CD25+ Regulatory T Cells.

Dynamic Effects of Leflunomide on IL-1, IL-6, and TNF-alpha Activity Produced from Peritoneal Macrophages in Adjuvant Arthritis Rats.

Endoplasmic Reticulum Stress and MAPK Signaling Pathway Activation Underlie Leflunomide-Induced Toxicity in HepG2 Cells.

Effects of the active metabolite of leflunomide,A771726,on the immune function of LPS-stimulated peritoneal macrophages from collagen-induced arthritis rats in vitro

The Potential Role of Leflunomide in Inhibiting Vascular Fibrosis by Down-Regulating Type-Ii Macrophages in Takayasu's Arteritis.

Effect of Teriflunomide Combined with Methotrexate on Fibroblast-like Synoviocytes in Rheumatoid Arthritis

In vitro effect of A771726 on the secretion of nitric oxide of peritoneal macrophages from collagen-induced arthritis rats

Effects of Leflunomide on the Shift of T Cells in Collagen-induced Arthritis Rats

The effects of leflunomide on rat colitisinduced by trinitrobenzene sulfonic acid